Drugs / Sabin Inactivated Poliovirus Vaccine (Vero Cell)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03822754 | Jun → Sep 2018 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Inactivated Poliovirus Vaccine (Vero Cell) | “A Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in a '1+2' Sequential...” NCT03822754 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03822754 ↗ |
| Modality | Vaccine | “Sabin Inactivated Poliovirus Vaccine (Vero cell)” NCT03822754 ↗ |
| Route | Intramuscular | “Single intramuscular injection of the experimental sIPV (0.5 ml)” NCT03822754 ↗ |